Carevalue Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 20-12-2024
- Paid Up Capital ₹ 5.00 Cr
as on 20-12-2024
- Company Age 5 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 20.68 Cr
as on 20-12-2024
- Revenue 241.97%
(FY 2022)
- Profit 208.94%
(FY 2022)
- Ebitda 185.30%
(FY 2022)
- Net Worth 6328.02%
(FY 2022)
- Total Assets 261.02%
(FY 2022)
About Carevalue Lifesciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 5.00 Cr.
The company currently has active open charges totaling ₹20.68 Cr.
Vinay Bohra, Vimal Bohra, and Arjun Bohra serve as directors at the Company.
- CIN/LLPIN
U74995UR2019PTC009510
- Company No.
009510
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Feb 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Company Details
- Location
Udham Singh Nagar, Uttarakhand, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Carevalue Lifesciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vimal Bohra  | Director | 12-Aug-2021 | Current |
| Vinay Bohra | Director | 13-Feb-2019 | Current |
| Arjun Bohra | Director | 13-Feb-2019 | Current |
Financial Performance of Carevalue Lifesciences.
Carevalue Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 241.97% increase. The company also saw a substantial improvement in profitability, with a 208.94% increase in profit. The company's net worth Soared by an impressive increase of 6328.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Carevalue Lifesciences?
In 2022, Carevalue Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bohra Health Care Private LimitedActive 38 years 10 monthsVinay Bohra and Arjun Bohra are mutual person
- Vardan Premium Health Care Private LimitedActive 13 years 4 months
Vinay Bohra and Arjun Bohra are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Sep 2023 | ₹10.68 Cr | Open |
Others Creation Date: 22 Sep 2021 | ₹10.00 Cr | Open |
How Many Employees Work at Carevalue Lifesciences?
Carevalue Lifesciences has a workforce of 16 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Carevalue Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Carevalue Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
